Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Fracture

Fracture

Proton pump inhibitors’ use and risk of hip fracture: A systematic review and meta-analysis

This systematic review and meta-analysis were performed with the aim to quantify the risk of hip fracture associated with proton pump inhibitor use [read more].
Hussain S et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4142-x

Proton pump inhibitors’ use and risk of hip fracture: A systematic review and meta-analysis

29-08-2018 | Osteoporosis | Review | Article

Proton pump inhibitors’ use and risk of hip fracture: A systematic review and meta-analysis

Hussain S et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4142-x

07-08-2018 | Rheumatoid arthritis | News

Disease activity linked to osteoporotic fracture risk in RA patients

Patients with rheumatoid arthritis who have high cumulative disease activity and functional disability have an elevated 10-year risk for osteoporotic fracture, researchers report.

Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis

This study aimed to examine the relationship between medication persistence and fracture risk among female Medicare beneficiaries diagnosed with osteoporosis [read more].
Liu J et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4630-6

Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis

23-07-2018 | Osteoporosis | Article

Incidence, risk factors, and fracture healing of atypical femoral fractures: A multicenter case-control study

Lim SJ et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4640-4

20-07-2018 | Osteoporosis | Article

Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older

van der Velde RY et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4636-0

18-07-2018 | Osteoporosis | Article

Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis

Liu J et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4630-6

26-06-2018 | Osteoporosis | Article

Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis

Li L et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4185-0

21-06-2018 | Osteoporosis | Review | Article

Physical activity for fall and fracture prevention

The aim of this review is to provide healthcare professionals with evidence-based physical activity recommendations, and tips for implementing them in practice.

Ponzano M, Rodrigues IB, Giangregorio LM. Curr Treat Options in Rheum 2018. doi: 10.1007/s40674-018-0103-5

21-06-2018 | Osteoporosis | Article

Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys

Yoshimura N et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4596-4

Physical activity for fall and fracture prevention

The aim of this review is to provide healthcare professionals with evidence-based physical activity recommendations, and tips for implementing them in practice [read more].
Ponzano M, Rodrigues IB, Giangregorio LM. Curr Treat Options in Rheum 2018. doi: 10.1007/s40674-018-0103-5



Physical activity for fall and fracture prevention

18-06-2018 | Osteoporosis | Article

Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: A cross-sectional study

Inoue, Y et al. Pediatr Rheumatol 2018; 16: 36. doi: 10.1186/s12969-018-0258-5

12-06-2018 | Osteoporosis | Article

Characteristics of recurrent fractures

Kanis JA et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4502-0

04-06-2018 | Osteoporosis | Review | Article

Review of the guideline of the American College of Physicians on the treatment of osteoporosis

Kanis, JA et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4504-y

31-05-2018 | Osteoporosis | View from the clinic | Article

Managing osteoporosis in pediatric patients

Editorial board member Sangeeta Sule discusses the causes of low bone mineral density and osteoporosis in pediatric patients with rheumatic diseases, and suggests strategies for risk prevention and treatment of this disease.

22-05-2018 | Osteoporosis | Article

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride

Antoniou T et al. BMC Musculoskelet Disord 2018; 19: 160. doi: 10.1186/s12891-018-2076-9

17-05-2018 | Osteoporosis | Article

Anti-osteoporosis drug use: Too little, too much, or just right? The HUNT study, Norway

Hoff M et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4560-3

14-05-2018 | Osteoporosis | Article

Prevalence and comorbidity of osteoporosis: A cross-sectional analysis on 10,660 adults aged 50 years and older in Germany

Puth MT et al. BMC Musculoskelet Disord 2018; 19: 144. doi: 10.1186/s12891-018-2060-4

08-05-2018 | Osteoarthritis | Article

Benefits and safety of dietary protein for bone health: An expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

This summary of systematic reviews and meta-analyses addresses the benefits and risks of dietary protein intakes for bone health in adults.

Rizzoli R et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4534-5

Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

This summary of systematic reviews and meta-analyses addresses the benefits and risks of dietary protein intakes for bone health in adults [read more].
Rizzoli R et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4534-5

Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation
Next Previous
Image Credits